Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective

Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective

Abstract Background Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prostate radio therapy (RT) in addition to standard of care (SOC). The objec...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristina K. M. Kramer, Nina-Sophie Schmidt-Hegemann, Thilo Westhofen, Marco Foglar, Jens Ricke, C. Benedikt Westphalen, Marcus Unterrainer, Wolfgang G. Kunz, Dirk Mehrens
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Radiation Oncology
Subjects:
Cost-effectiveness
Prostate cancer
Radiotherapy
Bone metastases
NRLN metastases
Online Access:https://doi.org/10.1186/s13014-024-02544-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13014-024-02544-0

Similar Items